Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Scolr Pharma, a specialty pharmaceutical company, has appointed Bruce Morra as its new president and CEO. Dr Morra has served as a member of the Scolr Pharma board of directors since August 2007.
Subscribe to our email newsletter
Since 1998, Dr Morra has been a board member and consultant for various public and private life science companies. Dr Morra has previously served as the president of West Pharmaceutical Services drug delivery and contract clinical research businesses.
Dr Morra has received his BSE in chemical engineering from Princeton, a PhD in polymer science and engineering and an MBA from the University of Massachusetts at Amherst.
Michael Taglich, chairman of board of directors, said, “We are very pleased that Dr Morra has agreed to become Scolr Pharma’s CEO. Since Dr Morra’s appointment to the board, he has been an able and trusted advisor.
“Given our longstanding belief that Scolr’s success will stem from maximizing opportunities for our Controlled Delivery Technology in the pharmaceutical and over-the-counter arena, Dr Morra’s level of experience earned as an executive at numerous specialty pharmaceutical and healthcare companies coupled with his strategic alliance and business development expertise, makes him the right executive to assume leadership of our company.”